Polpharma passed an inspection by the Food and Drug Administration (FDA). As a result, APIS manufactured by the company gained access to the highly developed US market.

The parent company of Polpharma Group is situated in the Netherlands:

Polpharma Group B.V.

COC: Amsterdam nr. 33250246

 

© Polpharma Group B.V. 2023. All rights reserved.

Herengracht 480, 1017 CB Amsterdam, The Netherlands
+31 (0)20 705 4800